P2Y12 inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trialsDevika Aggarwal, Arman Qamar, Thomas A. Zelniker et al.|European Heart Journal Open|2022Cited by 39